(Q36554430)

14 August 2017

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies (English)

1 reference

14 August 2017

0 references

1 reference

15

Gennaro Cormio

1 reference

14 August 2017

13

Giovanni Scambia

1 reference

14 August 2017

Thomas Hogberg

1

1 reference

14 August 2017

Mauro Signorelli

2

1 reference

14 August 2017

Carlos Freire de Oliveira

3

1 reference

14 August 2017

Roldano Fossati

4

1 reference

14 August 2017

Andrea Alberto Lissoni

5

1 reference

14 August 2017

Bengt Sorbe

6

1 reference

14 August 2017

Håkan Andersson

7

1 reference

14 August 2017

Seija Grenman

8

1 reference

14 August 2017

Caroline Lundgren

9

1 reference

14 August 2017

Per Rosenberg

10

1 reference

14 August 2017

Karin Boman

11

1 reference

14 August 2017

Bengt Tholander

12

1 reference

14 August 2017

Nicholas Reed

14

1 reference

14 August 2017

Germana Tognon

16

1 reference

14 August 2017

Jackie Clarke

17

1 reference

14 August 2017

Tomasz Sawicki

18

1 reference

14 August 2017

Paolo Zola

19

1 reference

14 August 2017

Gunnar Kristensen

20

1 reference

14 August 2017

7 July 2010

1 reference

European Journal of Cancer

14 August 2017

1 reference

14 August 2017

46

1 reference

14 August 2017

13

1 reference

14 August 2017

2422-2431

1 reference

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3552301

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3552301

Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3552301

Global cancer statistics, 2002

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3552301

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3552301

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3552301

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3552301

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3552301

Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3552301

Modified Radical Hysterectomy Versus Extrafascial Hysterectomy in the Treatment of Stage I Endometrial Cancer: Results From the ILIADE Randomized Study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3552301

Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer

4 December 2018

1 reference

12 December 2020

Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study

1 reference

12 December 2020

Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients

1 reference

12 December 2020

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

1 reference

12 December 2020

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

1 reference

12 December 2020

10.1016/J.EJCA.2010.06.002

Identifiers

DOI

1 reference

OpenCitations bibliographic resource ID

14 August 2017

0 references

1 reference

14 August 2017

1 reference